A recent CDC report further demonstrates the effectiveness of the HPV vaccine against cervical cancer. HPV is a sexually transmitted infection that affects both females and males and is linked to higher risks of various forms of cancer.

A new government report says that rates for precancerous lesions decreased about 80% among younger women who were screened for cervical cancer.

A new CDC report finds that rates of precancerous lesions detected in women ages 20 to 24 have decreased by nearly 80%, lesions that would likely develop into cervical cancer years later.

Because almost all cases of cervical cancer can be traced to HPV, some countries think the vaccine will help them eliminate the disease within years.

Awareness Day, observed annually on 4 March, serves as a crucial reminder of the link between HPV and cervical cancer. The Cancer Association of South Africa (Cansa) supports the International Papillomavirus Society’s (IPVS) initiative to address the urgent need to raise awareness about this common virus and its potential harm.

The Department of Health is rolling out the first round of Human Papilloma Virus (HPV) vaccinations for girls between the ages of 9 and 14 until March 28, so Bonitas Medical Fund is putting the spotlight on HPV and cervical cancer.

A CDC report shows a dramatic drop in precancerous HPV lesions in young women. Here’s why the HPV vaccine is beneficial.

These vaccines are nearly 100% effective if they're given prior to exposure to the HPV types they cover. And this is why the World Health Organization recommends them as a routine vaccination for girls aged between nine and 14 around the world.

The Christchurch-based study revealed the programme, running since 2008, has reduced cervical cancer by more than two-thirds and showed the vaccine was “incredibly important and makes a real difference”.

Learn the hidden dangers of HPV, its link to cancer, and how vaccination, screening, and awareness can help protect women's health.

New CDC data on falling rates of precancerous cervical lesions in the U.S. underscore the benefits of HPV vaccination.